A polyostotic Paget’s Disease of bone: a case report of a 50s Chinese male with mini review

Bones are not static pillars of stone; they are living tissue that constantly renews itself. In a healthy body, tiny cells called osteoclasts act as demolition crews, breaking down old bone, while other cells called osteoblasts act as construction workers, laying down new, strong material. This cycle keeps the skeleton resilient and able to repair itself. However, in a rare condition known as Paget's disease of bone, this careful balance collapses. The demolition crews become hyperactive, tearing down bone far too quickly, and the construction crews rush to fill the gap but do so in a chaotic, disorganized manner. The result is bone that is larger and denser than normal, yet structurally weak and prone to pain, deformity, or fracture. While this condition is well-documented in Europe and North America, it is rarely seen in Asia, leaving many doctors unfamiliar with its specific signs and symptoms.

This story begins with a fifty-three-year-old man in Shanghai who had been suffering from persistent pain in his left hip for five years. The discomfort worsened with movement and gradually made daily life difficult. For a year, doctors at other hospitals examined his X-rays and magnetic resonance images, which showed changes in the bone of his hip, and concluded he had a condition called osteonecrosis, where bone tissue dies due to a lack of blood supply. He was treated for this condition, but when the pain medications were stopped, the pain returned, suggesting the initial diagnosis was incorrect. The medical team at Zhongshan Hospital of Fudan University took a closer look. They found that his blood tests showed slightly elevated levels of a liver enzyme and a bone enzyme called alkaline phosphatase, which hinted that something was happening in his skeleton beyond just the hip.

To understand the full scope of the problem, the doctors performed a specialized scan of his entire body that tracks how bones use energy. The images revealed a startling pattern: the disease was not limited to his hip. The scan showed abnormal activity in his skull, his spine, his ribs, and both sides of his pelvis. Because the bones looked so dense and irregular, the team initially worried this might be cancer that had spread from another part of the body. To be certain, they performed a small biopsy, taking a tiny sample of bone from his lower back. Under a microscope, the tissue revealed a classic, unmistakable pattern known as a "mosaic" design. This pattern is created when the bone is constantly being broken down and rebuilt in a jumbled way, leaving behind irregular lines where old and new bone meet. This finding, combined with the presence of giant cells that were aggressively eating away at the bone, confirmed the true diagnosis: polyostotic Paget's disease of bone, meaning the disease was active in many bones at once.

Once the diagnosis was clear, the treatment plan shifted immediately. The patient received a single dose of a powerful medication called zoledronic acid, which works by calming the overactive cells that are destroying the bone. The response was rapid and significant. Within one month, the patient's severe hip pain had disappeared completely. By the six-month mark, a follow-up blood test showed that the level of the bone enzyme had dropped back to the normal range, indicating that the chaotic bone remodeling had been successfully halted. The doctors noted that while the medication could not reverse the structural changes that had already occurred in the bone, it effectively stopped the disease from causing further damage or pain.

This case is particularly important because it highlights a gap in medical knowledge within Asia. Paget's disease is so uncommon in China that it is often mistaken for other conditions, such as the osteonecrosis that initially misled this patient's doctors. The study serves as a reminder that when a patient presents with unexplained bone pain and unusual imaging results, especially if multiple bones are involved, doctors must consider this rare disorder. By sharing this specific case and a review of what is known about the disease, the researchers hope to improve recognition and ensure that patients in the future receive the correct diagnosis and effective treatment much sooner.